SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Barclays Maintains Encompass Health at Overweight, Raises Target to $151

Barclays maintained its Overweight rating and raised its price target from $144 to $151.

EHC
SquawkNews Desk 1 updates Updated Oct 29, 2026, 03:11 PM UTC

Story updates

03:11:17 PM UTC
SquawkNews
Encompass Health Price Target Raised to $151.00/Share From $144.00 by Barclays

Related stories

Intel Shares Fall 25.4% After Weak Q4 Guidance Intel forecast fourth-quarter adjusted EPS of 25 cents versus the 43-cent analyst estimate, and revenue of $15 billion to $16 billion versus $17.05 billion expected. Shares fell 25 H impact | EQUITY | Oct 30, 2026, 10:39 AM UTC Intel Shares Fall About 25% Premarket After Results Intel shares were down roughly 25% before the bell after the company posted results after hours yesterday. The move could erase around $120 billion from its market value. H impact | EQUITY | Oct 30, 2026, 10:38 AM UTC Cameco Reports Third-Quarter Results; Declares Annual Dividend Cameco reported third-quarter results and declared an annual dividend. The supplied text provides no financial figures or dividend terms. M impact | EQUITY | Oct 30, 2026, 10:32 AM UTC TXNM Energy Reports Q3 Results and Updates Blackstone Deal Timing TXNM Energy said Q3 2026 EPS was reduced by share issuances and transaction costs. Hearings on its Blackstone sale are set for Jan. 19–Feb. 1, 2027, with closing expected in H1 202 H impact | EQUITY | Oct 30, 2026, 10:31 AM UTC Ingersoll Rand Appoints Segment Leaders and Extends CEO Agreement Ingersoll Rand appointed Scott Watson to lead IT&S North America and EMEIA, and Shaun Carlson to lead P&ST. Its board approved a new employment agreement with CEO Vicente Reynal. M impact | EQUITY | Oct 30, 2026, 10:30 AM UTC ExxonMobil Announces Third-Quarter 2026 Results M impact | EQUITY | Oct 30, 2026, 10:30 AM UTC